Friday, July 10, 2026

pharma · Acute Coronary Syndrome

Xiangya Hospital of

Xiangya Hospital of clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Changsha, CN HQ
1906 Founded
316 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Changsha, CN
Founded
1906
Employees
316
Programs
1
Drugs
1
Patents
0
Intelligence · Clinical Programs

Xiangya Hospital of projects

1 ClinicalTrials.gov programs sponsored by Xiangya Hospital of.

Xiangya Hospital of has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. Rivaroxaban 2.5 mg

    Second Xiangya Hospital of Central South University

    Acute Coronary Syndrome

    approved small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does Xiangya Hospital of have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.